GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » EBIT

PRVA (Privia Health Group) EBIT : $17 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group EBIT?

Privia Health Group's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was $5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was $17 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Privia Health Group's annualized ROC % for the quarter that ended in Dec. 2024 was 2.02%. Privia Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 327.64%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Privia Health Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 0.66%.


Privia Health Group EBIT Historical Data

The historical data trend for Privia Health Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Privia Health Group EBIT Chart

Privia Health Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial 25.38 -217.44 -19.12 20.65 16.98

Privia Health Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 0.82 5.10 5.81 5.25

Competitive Comparison of Privia Health Group's EBIT

For the Health Information Services subindustry, Privia Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Privia Health Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Privia Health Group's EV-to-EBIT falls into.



Privia Health Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Privia Health Group  (NAS:PRVA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Privia Health Group's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=20.992 * ( 1 - 33.1% )/( (712.998 + 674.119)/ 2 )
=14.043648/693.5585
=2.02 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1145.565 - 58.287 - ( 421.997 - max(0, 479.473 - 853.753+421.997))
=712.998

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1135.783 - 75.987 - ( 491.149 - max(0, 449.146 - 834.823+491.149))
=674.119

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Privia Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=20.992/( ( (6.744 + max(-45.137, 0)) + (6.07 + max(-102.919, 0)) )/ 2 )
=20.992/( ( 6.744 + 6.07 )/ 2 )
=20.992/6.407
=327.64 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(408.959 + 0 + 22.797) - (58.287 + 0 + 418.606)
=-45.137

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(316.179 + 0 + 27.495) - (75.987 + 0 + 370.606)
=-102.919

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Privia Health Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=16.982/2570.951
=0.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Privia Health Group EBIT Related Terms

Thank you for viewing the detailed overview of Privia Health Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Privia Health Group Business Description

Traded in Other Exchanges
N/A
Address
950 North Glebe Road, Suite 700, Arlington, VA, USA, 22203
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Executives
David Mountcastle officer: Chief Financial Officer 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Parth Mehrotra officer: President and COO 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler director 1215 5TH AVE N,, NASHVILLE TN 37208
Thomas A Mccarthy director 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL18Y, PHILADELPHIA PA 19192
Thomas Bartrum officer: EVP, General Counsel 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Matthew Shawn Morris director, officer: Chief Executive Officer 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
William M Sullivan director ONE PENN PLAZA, SUITE 5300, NY NY 10119
Pamela O Kimmet director 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein director 200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p. 10 percent owner 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c. 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey B Butler director 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203